Macrophage activation syndrome in children with Kawasaki disease: diagnostic and therapeutic approaches

[1] Kawasaki T(1967)Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children Arerugi 16 178-222

[2] McCrindle BW(2017)Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association Circulation 135 e927-e999

[3] Rowley AH(1983)High-dose intravenous gammaglobulin for Kawasaki disease Lancet 2 1359-347

[4] Newburger JW(1986)The treatment of Kawasaki syndrome with intravenous gamma globulin N Engl J Med 315 341-75

[5] Burns JC(2019)Biomarkers of intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease World J Pediatr. 15 168-123

[6] Bolger AF(2019)Predictors and management of intravenous immunoglobulin-resistant Kawasaki disease Korean J Pediatr 62 119-240

[7] Gewitz M(2006)Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease J Pediatr 149 237-1053

[8] Furusho K(2015)Clinical features and correct diagnosis of macrophage activation syndrome Expert Rev Clin Immunol 11 1043-941

[9] Sato K(2019)The immunology of macrophage activation syndrome Front Immunol 10 119-566

[10] Soeda T(2015)Macrophage activation syndrome Hematol Oncol Clin North Am 29 927-20

[1] Kawasaki T(1967)Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children Arerugi 16 178-222

[2] McCrindle BW(2017)Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association Circulation 135 e927-e999

[3] Rowley AH(1983)High-dose intravenous gammaglobulin for Kawasaki disease Lancet 2 1359-347

[4] Newburger JW(1986)The treatment of Kawasaki syndrome with intravenous gamma globulin N Engl J Med 315 341-75

[5] Burns JC(2019)Biomarkers of intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease World J Pediatr. 15 168-123

[6] Bolger AF(2019)Predictors and management of intravenous immunoglobulin-resistant Kawasaki disease Korean J Pediatr 62 119-240

[7] Gewitz M(2006)Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease J Pediatr 149 237-1053

[8] Furusho K(2015)Clinical features and correct diagnosis of macrophage activation syndrome Expert Rev Clin Immunol 11 1043-941

[9] Sato K(2019)The immunology of macrophage activation syndrome Front Immunol 10 119-566

[10] Soeda T(2015)Macrophage activation syndrome Hematol Oncol Clin North Am 29 927-20